Project Overview

Active Biotech focuses on the research and development of pharmaceuticals in therapeutic areas with high medical need and in which the body’s immune system is of central importance. The project portfolio comprises small, orally active immunomodulatory molecules as well as antibody-based immunotherapy. The projects are in development for cancer and autoimmune/inflammatory diseases.

Therapeutic areas of high medical need

Pipeline

Disease Area
Discovery
Preclinical
Phase I
Phase II
Phase III
Partner
Cancer
Naptumomab Combination with anti-PDL1 (durvalumab) in solid tumors
Naptumomab Combination with docetaxel in Non-small cell lung cancer*
Tasquinimod Multiple myeloma**
Inflammation
Laquinimod Uveitis
Study ongoing
Preclinical activities ongoing
* Study preparations ongoing
** In an academic partnership with the Abramson Cancer Center, Philadelphia, University of Pennsylvania